Nevertheless, our data implicated a possible vicious loop in the pathogenesis of anti-MDA5+ DM, i.e., trigger-activated (viral) type I IFN pathway and subsequent adaptive immune response (including the generation of anti-MDA5+ autoantibody). This evidence concerns the gene IFIH1 and dermatomyositis.